|
|
 |
|
Viewing report
|
|
|
|
Analgesics in Japan
Euromonitor International, April 2012, Pages: 41
Adult analgesics value sales grew by 8% in 2011. Strong growth was observed particularly in combination products – analgesics, where major hit product Loxonin S is included. Loxonin S had sales of over ¥3 billion and quickly gained a market share of 7% in 2011. The launch of Loxonin S helped push up the market size of combination products – analgesics, and the category as a whole grew with other major brands’ favourable sales performances. The top two brands, SSP Co Ltd’s Eve A and Lion Corp’s...
The Analgesics in Japan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Analgesics market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
|
|
|
|
